HOME >> MEDICINE >> NEWS
Study shows drug can heal, reduce recurrence of fistulas in Crohn's disease

An international study has found that maintenance therapy with the drug infliximab, a monoclonal antibody used to treat Crohn's disease, can prevent or delay the recurrence of fistulas, a common complication of that inflammatory bowel disorder. As reported in the February 26 New England Journal of Medicine, patients receiving infliximab on a regular basis were twice as likely to avoid fistula recurrence than were patients receiving a placebo.

The study was largely supported by the pharmaceutical firm Centocor, a subsidiary of Johnson & Johnson, which markets infliximab under the brand name Remicade.

Crohn's disease is a chronic inflammatory disorder of the digestive tract that affects about half a million people in the U.S. Patients with more severe symptoms may develop fistulas openings from affected areas of the intestine into other organs or onto the skin, often around the anus. The presence of fistulas can seriously impact patients' quality of life and increases the likelihood of surgical treatment, which may not have satisfactory results. Infliximab, which targets the inflammatory protein tumor necrosis factor, has been shown in previous research to reduce symptoms in patients without this complication and to heal fistulas over a limited period of time.

"Fistulas can be a devastating complication of Crohn's disease," says Bruce Sands, MD, of the Massachusetts General Hospital (MGH) Gastrointestinal Unit, lead author of the report. "While neither medical nor surgical therapy is perfect in treating this complication, our study has shown that maintenance treatment with infliximab can produce durable closure of fistulas in many patients."

The current study carried out at 45 sites in North America, Europe and Israel enrolled adult patients with fistulizing Crohn's disease not previously treated with infliximab. Almost 300 participants completed a preliminary phase of treatment, receiving three intravenous doses of infliximab
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
25-Feb-2004


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/2/2020)... ... , ... Since the onset of the COVID-19 pandemic, there hasn’t yet been ... https://www.goparrot.ai/ ) founder Yaniv Nissim has stepped up to the plate to address this ... created new standards for delivering food during this time of COVID-19 so that consumers ...
(Date:4/1/2020)... ... April 01, 2020 , ... According to data released by Power ... in need of publicly funded contraception live in counties impacted by the implementation of ... have lost some or all of their Title X resources. , The domestic ...
(Date:4/1/2020)... SAN FRANCISCO (PRWEB) , ... April 01, 2020 ... ... most personal and private of information under California law,” says Keller Grover LLP ... give patients timely notice of data breaches and the negligent release and disclosure ...
(Date:3/28/2020)... ... March 27, 2020 , ... With social distancing, ... grow by the day, people of all ages are challenged to find different ... social interactions in the best of times—the physical distance mandated to prevent the ...
(Date:3/28/2020)... CINCINNATI (PRWEB) , ... March 28, 2020 , ... ... revenue cycle management services, integrated practice management, and patient engagement solutions has expanded ... coronavirus outbreak. , In this time of crisis, telemedicine has a big ...
Breaking Medicine News(10 mins):
(Date:4/7/2020)... ... April 07, 2020 , ... ... serve their customers. Concerns over Coronavirus (COVID-19), has led to an increased focus ... retailers, laboratories, pharmacies, medical centers and others. How businesses and customers physically interact ...
(Date:4/5/2020)... ... April 04, 2020 , ... In a time of strife, ... producing non-medical cloth facemasks. , On March 18th when SwaddleDesigns (located in Seattle, ... face masks if no medical-grade facemasks were available, SwaddleDesigns founder& CEO, Lynette Damir ...
(Date:4/5/2020)... , ... April 04, 2020 , ... ... infections, urgent needs arise for medical supplies, diagnostics, and treatments. Shortages of such ... professionals at risk. , Tran & Associates supports the fight against ...
Breaking Medicine Technology:
Cached News: